Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Breast Neoplasms 930Neoplasms 708Prostatic Neoplasms 490Lung Neoplasms 398Carcinoma, Non-Small-Cell Lung 359Colorectal Neoplasms 357Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 238Brain Neoplasms 227Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 182Glioblastoma 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Melanoma 173Ovarian Neoplasms 168Squamous Cell Carcinoma of Head and Neck 160Uterine Cervical Neoplasms 144Rectal Neoplasms 144Recurrence 142Hematologic Neoplasms 134Sarcoma 133Triple Negative Breast Neoplasms 127Stomach Neoplasms 127Glioma 126Carcinoma, Renal Cell 123Colonic Neoplasms 113Myelodysplastic Syndromes 112Urinary Bladder Neoplasms 109

Interventions

Tacrolimus 1Sirolimus 1Mitomycin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pseudomyxoma Peritonei × 90 days × Clear all
NCT06084780 2026-04-09

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
20 enrolled

Pseudomyxoma Peritonei

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Jules Bordet Institute

Recruiting
500 enrolled
GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡